Assessment of myocardial mechanics in overweight and obese Indian subjects

Insights

Obesity directly impacts heart function, causing subclinical diastolic dysfunction even in mild cases. Body Mass Index (BMI) correlates with these changes, highlighting the cardiovascular risks of excess weight.

Area of Science:

  • Cardiology
  • Obesity Medicine
  • Diagnostic Imaging

Background:

  • Obesity is a known risk factor for cardiovascular disease.
  • The direct impact of isolated obesity on cardiac function remains unclear.
  • Understanding these effects is crucial for early intervention.

Purpose of the Study:

  • To investigate the direct effects of varying obesity grades on left ventricular systolic and diastolic function.
  • To assess echocardiographic indices in overweight and obese individuals compared to normal weight controls.
  • To determine the correlation between Body Mass Index (BMI) and cardiac function parameters.

Main Methods:

  • Cross-sectional study comparing normal weight, overweight, and obese serving personnel.
  • Echocardiography used to measure left ventricular dimensions and systolic/diastolic function indices.
  • Dysfunction defined as values deviating by ≥2 standard deviations from the normal weight group.

Main Results:

  • Increased ejection fraction and fractional shortening observed in overweight and obese groups.
  • Left ventricular dimensions were enlarged, but relative wall thickness remained unchanged.
  • Subclinical diastolic dysfunction, characterized by increased deceleration time and reduced E/A ratio, was prevalent across all obesity grades and correlated with BMI.

Conclusions:

  • Isolated obesity, across all grades, leads to subclinical left ventricular diastolic dysfunction.
  • Systolic function was not impaired in the studied obese population.
  • BMI is a significant correlate of left ventricular diastolic dysfunction in obesity.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
541